GSK Plc Correlations
| GLAXF Stock | USD 16.87 0.17 1.00% |
The current 90-days correlation between GSK plc and Pfizer Inc is 0.11 (i.e., Average diversification). The correlation of GSK Plc is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
GSK Plc Correlation With Market
Significant diversification
The correlation between GSK plc and DJI is 0.04 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding GSK plc and DJI in the same portfolio, assuming nothing else is changed.
GSK |
The ability to find closely correlated positions to GSK Plc could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace GSK Plc when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back GSK Plc - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling GSK plc to buy it.
Moving together with GSK Pink Sheet
| 0.84 | LLY | Eli Lilly | PairCorr |
| 0.81 | JNJ | Johnson Johnson Fiscal Year End 28th of January 2025 | PairCorr |
| 0.94 | MRK | Merck Company Fiscal Year End 6th of February 2025 | PairCorr |
| 0.74 | RHHBY | Roche Holding | PairCorr |
| 0.73 | RHHVF | Roche Holding AG | PairCorr |
| 0.87 | AZNCF | AstraZeneca PLC | PairCorr |
| 0.87 | AZN | AstraZeneca PLC ADR | PairCorr |
| 0.84 | NVS | Novartis AG ADR | PairCorr |
| 0.75 | NVSEF | Novartis AG | PairCorr |
Moving against GSK Pink Sheet
| 0.83 | PYPL | PayPal Holdings Aggressive Push | PairCorr |
| 0.82 | NFLX | Netflix Fiscal Year End 28th of January 2025 | PairCorr |
| 0.72 | GOOG | Alphabet Class C Aggressive Push | PairCorr |
| 0.62 | RUM | Rumble Inc | PairCorr |
| 0.55 | BBAI | BigBearai Holdings | PairCorr |
| 0.39 | ICAD | icad inc | PairCorr |
| 0.9 | AVTE | Aerovate Therapeutics | PairCorr |
| 0.87 | BAC | Bank of America Fiscal Year End 10th of January 2025 | PairCorr |
| 0.86 | SOFI | SoFi Technologies Aggressive Push | PairCorr |
| 0.84 | IONQ | IONQ Inc Upward Rally | PairCorr |
| 0.83 | PLTR | Palantir Technologies Buyout Trend | PairCorr |
| 0.81 | CRS | Carpenter Technology | PairCorr |
| 0.79 | FUND | Sprott Focus Trust | PairCorr |
| 0.76 | ET | Energy Transfer LP | PairCorr |
| 0.74 | LUNR | Intuitive Machines | PairCorr |
| 0.73 | BFLY | Butterfly Network | PairCorr |
| 0.62 | INMD | InMode | PairCorr |
| 0.62 | APLD | Applied Blockchain | PairCorr |
| 0.55 | SOUN | SoundHound AI Upward Rally | PairCorr |
| 0.44 | SDIG | Stronghold Digital Mining | PairCorr |
Related Correlations Analysis
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between GSK Pink Sheet performing well and GSK Plc Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze GSK Plc's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| SNPHF | 0.91 | (0.14) | 0.00 | (0.53) | 0.00 | 2.70 | 15.41 | |||
| OPHLY | 1.23 | (0.31) | 0.00 | 6.72 | 0.00 | 2.09 | 10.36 | |||
| GRFS | 2.02 | (0.30) | 0.00 | (2.20) | 0.00 | 5.06 | 20.33 | |||
| PFE | 1.07 | (0.20) | 0.00 | (0.73) | 0.00 | 2.07 | 8.17 | |||
| SNY | 0.82 | (0.30) | 0.00 | (3.05) | 0.00 | 1.13 | 7.81 | |||
| RHHBY | 0.81 | (0.13) | 0.00 | 0.79 | 0.00 | 1.20 | 5.51 | |||
| NVS | 0.67 | (0.26) | 0.00 | (5.93) | 0.00 | 1.12 | 6.05 | |||
| AMGN | 1.09 | (0.37) | 0.00 | (0.31) | 0.00 | 1.85 | 9.43 | |||
| GILD | 0.92 | 0.12 | 0.05 | 0.33 | 1.19 | 1.94 | 10.79 | |||
| RHHVF | 1.09 | (0.12) | 0.00 | 0.55 | 0.00 | 2.01 | 5.43 |
Be your own money manager
Our tools can tell you how much better you can do entering a position in GSK Plc without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Portfolio Analyzer Now
Portfolio AnalyzerPortfolio analysis module that provides access to portfolio diagnostics and optimization engine |
| All Next | Launch Module |
GSK Plc Corporate Management
| David Redfern | Chief Strategy Officer | Profile | |
| Diana Conrad | Chief Officer | Profile | |
| Sally Jackson | VP Office | Profile | |
| Shobie Ramakrishnan | Chief Officer | Profile |